| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc8e3afbfcf74ffac2aeccd8e3b0eee2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_504f4b6d7adc268fdb422cd7917230a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f2d101ec1c2e1e497762ba78477c13a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2011-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92d0a307b3b30e03ef3d05663a7a72a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d53d9ecce986b5ca1866f8dc93de20c |
| publicationDate |
2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011145125-A1 |
| titleOfInvention |
Chimeric biomarker for the early diagnosis and immunotherapy of cancer |
| abstract |
This invention refers to DNA and RNA molecules that encode fusion polypeptides containing or derived from the amino acid sequence called EASI- PRO which contains the sequence RTNKEASI. More specifically, the invention involves products of nucleic acids and polypeptides obtained as a result of alternative splicing mechanisms and compositions containing all or part of the EASI -PRO sequence. In addition, the invention refers to antibodies and oligonucleotides as tools for the detection of new markers to be used in the molecular diagnostics of cancer. Finally, the invention refers to anti-cancer vaccines based on the protein containing the EASI -PRO sequence and on the nucleic acid molecules described above, and to therapeutic antibodies and drugs intended to inhibit the function of this protein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012163789-A1 |
| priorityDate |
2010-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |